Health and Drug Alerts | 合法醫療器材資訊網

Cypher is a brand of drug-eluting coronary stent from Cordis Corporation, a Cardinal Health company. During a balloon angioplasty, the stent is inserted into the ... Read More

Use of more than two CYPHER Stents will result in the patient receiving larger amounts of drug and polymer than the experience reflected in the clinical studies. Read More

The first DES to be implanted in humans was the Cypher stent (Cordis Corp.). The pharmacological agent in this stent is the macrocyclic lactone, sirolimus. Read More

... 抑制引起硬化的物質，抑制細胞生長的物質,分子生物法，於是就發展出藥物釋放支架的新世代產品，如CYPHER® Sirolimus-eluting Coronary Stent 及TAXUS® ... Read More

由 A Chieffo 著作 · 2007 · 被引用 22 次 — Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions. Alaide Chieffo, Tiziana Claudia ... Read More

由 SB Choi 著作 · 2003 · 被引用 18 次 — The CYPHER stent, a metal device that is coated with sirolimus, was approved in April 2003 by the US Food and Drug Administration (FDA) for use in angioplasty​ ... Read More

2010年9月1日 — The patient, who was treated with the Cypher stent at the age of 75 after her coronary angiography showed a significant, single, de novo lesion in ... Read More

由 A Abizaid 著作 · 2012 · 被引用 15 次 — The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter ... Read More